CABERGOLINE - AN ADVANCE IN DOPAMINERGIC THERAPY

被引:13
作者
BEVAN, JS [1 ]
DAVIS, JRE [1 ]
机构
[1] MANCHESTER ROYAL INFIRM,DEPT ENDOCRINOL,MANCHESTER M13 9WL,LANCS,ENGLAND
关键词
D O I
10.1111/j.1365-2265.1994.tb02782.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:709 / 712
页数:4
相关论文
共 29 条
  • [1] DOPAMINE AGONISTS AND PITUITARY-TUMOR SHRINKAGE
    BEVAN, JS
    WEBSTER, J
    BURKE, CW
    SCANLON, MF
    [J]. ENDOCRINE REVIEWS, 1992, 13 (02) : 220 - 240
  • [2] BEVAN JS, 1993, ENDOCRINE REV MONOGR, V1, P211
  • [3] PLEUROPULMONARY DISEASE ASSOCIATED WITH DOPAMINE AGONIST THERAPY
    BHATT, MH
    KEENAN, SP
    FLEETHAM, JA
    CALNE, DB
    [J]. ANNALS OF NEUROLOGY, 1991, 30 (04) : 613 - 616
  • [4] EFFECTS OF THE DOPAMINE AGONIST CV 205-502 IN HUMAN PROLACTINOMAS RESISTANT TO BROMOCRIPTINE
    BRUE, T
    PELLEGRINI, I
    GUNZ, G
    MORANGE, I
    DEWAILLY, D
    BROWNELL, J
    ENJALBERT, A
    JAQUET, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (03) : 577 - 584
  • [5] EFFECTIVENESS AND TOLERABILITY OF LONG-TERM TREATMENT WITH CABERGOLINE, A NEW LONG-LASTING ERGOLINE DERIVATIVE, IN HYPERPROLACTINEMIC PATIENTS
    CICCARELLI, E
    GIUSTI, M
    MIOLA, C
    POTENZONI, F
    SGHEDONI, D
    CAMANNI, F
    GIORDANO, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (04) : 725 - 728
  • [6] LONG-TERM TREATMENT WITH ORAL SINGLE ADMINISTRATION OF BROMOCRIPTINE IN PATIENTS WITH HYPERPROLACTINEMIA
    CICCARELLI, E
    MAZZA, E
    GHIGO, E
    GUIDONI, F
    BARBERIS, A
    MASSARA, F
    CAMANNI, F
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1987, 10 (01) : 51 - 53
  • [7] DOPAMINERGIC TREATMENTS FOR HYPERPROLACTINEMIA
    CROSIGNANI, PG
    FERRARI, C
    [J]. BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1990, 4 (03): : 441 - 455
  • [8] INHIBITORY EFFECT OF CABERGOLINE ON THE DEVELOPMENT OF ESTROGEN-INDUCED PROLACTIN-SECRETING ADENOMAS OF THE PITUITARY
    DALLARA, A
    LIMA, L
    COCCHI, D
    DISALLE, E
    CANCIO, E
    DEVESA, J
    MULLER, EE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 151 (01) : 97 - 102
  • [9] CABERGOLINE - LONG-ACTING ORAL TREATMENT OF HYPERPROLACTINEMIC DISORDERS
    FERRARI, C
    MATTEI, A
    MELIS, GB
    PARACCHI, A
    MURATORI, M
    FAGLIA, G
    SGHEDONI, D
    CROSIGNANI, PG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (06) : 1201 - 1206
  • [10] CABERGOLINE IN THE LONG-TERM THERAPY OF HYPERPROLACTINEMIC DISORDERS
    FERRARI, C
    PARACCHI, A
    MATTEI, AM
    DEVINCENTIIS, S
    DALBERTON, A
    CROSIGNANI, P
    [J]. ACTA ENDOCRINOLOGICA, 1992, 126 (06): : 489 - 494